UNSPSC 85812416: Introduction of liquid brachytherapy radioisotope into mouth and pharynx, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of liquid brachytherapy radioisotope into mouth and pharynx, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0D704

UNSPSC 85812416 Introduction of liquid brachytherapy radioisotope into mouth and pharynx, via natural or artificial opening, a Commodity code, shows no recent state and local procurement activity aligned with its specialized oncology scope. The recent opportunities tagged under this code span virtual urgent care services, occupational health services, medical director roles, opioid use disorder treatment, behavioral health services, and diverse healthcare staffing and administrative functions — none of which involve brachytherapy radioisotope introduction or head-and-neck cancer treatment. The code's nominal scope describes a precise clinical intervention requiring state-licensed radiation oncology infrastructure and specialized medical physics oversight, yet the procurement record reflects a broad tagging misalignment across state, county, and health authority buyers nationwide.

Inland Empire Health Plan (California) issued an RFI on October 16, 2026 for virtual urgent care delivery; DeKalb County, Georgia posted an RFP on October 12, 2026 for general medical services; the Nevada Health Authority solicited PACE operations (October 8, 2026) and rural value-based care facilitation (October 7, 2026); San Mateo County requested cancer registry services (October 5, 2026) and retinal screening devices (October 1, 2026); and Santa Clara County Health System sought travel nurse staffing (September 17, 2026) and multisystemic therapy services (July 21, 2026). Geographic activity spans California, Georgia, Nevada, Colorado, Florida, Texas, Oregon, and the District of Columbia, with no concentration in any jurisdiction. The procedural mismatch between code definition and actual procurements suggests either systematic miscoding at issuance or a data integrity issue in the source system. For firms evaluating brachytherapy or oncology radiation services capacity, this code warrants skipping pending clarification from state procurement offices on proper classification.